An IBD patient with an ostomy bag - Getty ImagesA first of its kind online body image and wellbeing program designed to help ...

Number 5: Pediatric infliximab biosimilar use has risen significantly, reflecting evolving treatment patterns in inflammatory ...

In a groundbreaking healthcare milestone, Abu Dhabi has become the first region outside the United States to offer Tremfya, a next-generation biologic medication for patients with inflammatory bowel ...

Individuals with IBD, especially CD, have an increased risk for myocardial infarction, ischemic heart disease, cerebrovascular accident, and major adverse cardiovascular events.

Individuals with ulcerative colitis have an increased risk for certain types of cancer based on age, instead of treatment type.

We read with great interest the article by Lee et al ,1 who performed an open-label clinical trial to compare the effects of per os (PO) versus intravenous iron replacement therapy (IRT) for iron ...

Bristol-Myers Squibb terminated a real-world, non-interventional study on Ozanimod, targeting moderate-to-severe ulcerative ...

From fecal transplants to phage cocktails, scientists reveal how gut viruses could unlock precision medicine for digestive diseases and beyond.

The ACG has published new health maintenance recommendations for patients with IBD, which include appropriate vaccinations, ...

Background The development of IBD is known to involve early immunological alterations, but our understanding of the changes ...

Patients with ID receiving TNF inhibitors are at greater risk for cutaneous malignancy than patients who are biologic-naïve.

Bhat: With the rapidly advancing landscape of IBD treatments and the increasing complexities of the health care system, ...